Stocks · Health care · Pharmaceutical Preparations

Dianthus Therapeutics, Inc.

DNTH Clue Score33

United States Fiscal year ends December CIK 0001690585 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$71.20M

$0.00 on a plan · $71.20M straight out of an exercise

Sold at will

$0.00

0 of 66 sales

Net

−$71.20M

$0.00 against sales at will